Search - tctmd.com

Displaying 21 - 40 of 60

Sort: Relevancy | Date

Presentation VIVA 2017

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Presenter: Ehrin J. Armstrong

September 19, 2017

News Industry News

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

September 19, 2017

News Conference News VIVA 2017

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

L.A. McKeown

September 18, 2017

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

Presentation VIVA 2017

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

Presenter: Michael Dake

September 14, 2017

News Conference News VIVA 2017

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

L.A. McKeown

September 13, 2017

News Industry News

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

September 12, 2017

News Conference News ESC 2017

Acute MI Mortality Has Dropped to Very Low Levels in France

Todd Neale

September 08, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Conference News ESC 2017

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

Shelley Wood

August 28, 2017

News Conference News ESC 2017

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Todd Neale

August 27, 2017

News Daily News

Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients

Yael L. Maxwell

August 22, 2017

News Opinion Editor's Corner ESC 2017

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Shelley Wood

August 18, 2017

News Daily News

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

L.A. McKeown

August 03, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 27, 2017

News Industry News

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

July 26, 2017

News Daily News

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

L.A. McKeown

July 18, 2017

Podcast Heart Sounds

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Advertisement

Is Aspirin Really a Class I Medication in Peripheral Artery Disease?

Eurocor announces the presentation of the 12 months data of the Freeway Stent Study at CIRSE in Copenhagen

Low-Dose Paclitaxel DCB Shows Long-term Durability in Treating PAD

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan

DCBs, Stents, and ‘Swirling Flow’ Show Promise in Femoropopliteal Disease

Medtronic IN.PACT Admiral DCB Global Two Year Data and IN.PACT SFA Four Year Data Presented in VIVA Late Breaking Clinical Trials

Acute MI Mortality Has Dropped to Very Low Levels in France

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

VIVA: Could Population-Wide Screening Trial for AAA, PAD, and Hypertension Save Lives at Low Cost?

COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease

Closing the Mitral Gap: Early Pascal Experience Shows Promise for High-Risk MR Patients

ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On

Registry Confirms Long-term Durability of Drug-Coated Balloon for Femoropopliteal Lesions

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

Spectranetics Announces FDA Approval of Stellarex™ Drug-Coated Balloon

‘Surprising’ Uptick in Rates of Revascularization for In-Stent Restenosis

Top Stories in Cardiology, June 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content